Biochemistry Project – Bioluminescence – Video

Posted on by


Biochemistry Project - Bioluminescence
Bill Nye the Science Guy Parody - Bennett the Science Guy talks about bioluminescence References: Bioluminescence in the Sea Annual Review of Marine Science Vol. 2: 443-493 (Volume publication date January 2010) First published online as a Review in Advance on October 1, 2009 DOI: 10.1146/annurev-marine-120308-081028 scienceline.ucsb.edu http://www.rcsb.org Bioluminescence in the Ocean: Origins of Biological, Chemical, and Ecological Diversity EA Widder Science 7 May 2010: Vol. 328 no. 5979 pp. 704-708 DOI: 10.1126/science.1174269From:Genevieve JohnsonViews:2 0ratingsTime:10:21More inEducation

See the article here:
Biochemistry Project - Bioluminescence - Video

How to Pronounce Calciferol – Video

Posted on by


How to Pronounce Calciferol
Learn how to say Calciferol correctly with EmmaSaying #39;s "how do you pronounce" free tutorials. Definition of calciferol (oxford dictionary): noun [mass noun] Biochemistry one of the D vitamins, a sterol which is formed when its isomer ergosterol is exposed to ultraviolet light, and which is routinely added to dairy products. Also called ergocalciferol, vitamin D2. Origin: 1930s: from calciferous + -ol http://www.emmasaying.comFrom:Emma SayingViews:0 0ratingsTime:00:11More inHowto Style

Read more from the original source:
How to Pronounce Calciferol - Video

t-STEM Partnerships: Gaury Herman-Klinger – Video

Posted on by


t-STEM Partnerships: Gaury Herman-Klinger
UMBC and four Maryland community colleges have announced a partnership to ensure more transfer students succeed in STEM fields, funded by a $2.6 million Bill Melinda Gates Foundation grant. See http://www.umbc.edu This video features remarks by Gaury Herman-Klinger (MC/UUMBC), majoring in biochemistry and molecular biology.From:UMBC LifeViews:8 0ratingsTime:05:28More inEducation

Excerpt from:
t-STEM Partnerships: Gaury Herman-Klinger - Video

t-STEM Partnerships: Rima Abouzeid – Video

Posted on by


t-STEM Partnerships: Rima Abouzeid
UMBC and four Maryland community colleges have announced a partnership to ensure more transfer students succeed in STEM fields, funded by a $2.6 million Bill Melinda Gates Foundation grant. See http://www.umbc.edu This video features remarks by Rima Abouzeid (HCC/UMBC), majoring in biochemical engineering, biochemistry and biological sciences.From:UMBC LifeViews:29 0ratingsTime:02:16More inEducation

Link:
t-STEM Partnerships: Rima Abouzeid - Video

Why should students be exposed to problems in evolutionary theory? – Dr. Michael J. Denton – Video

Posted on by


Why should students be exposed to problems in evolutionary theory? - Dr. Michael J. Denton
Michael John Denton (born 25 August 1943) is a British-Australian author and biochemist. In 1973, Denton received his PhD in Biochemistry from King #39;s College London. Denton gained a medical degree from Bristol University in 1969 and a PhD from King #39;s College, London University in 1974. He was senior research fellow in the Biochemistry Department at the University of Otago, Dunedin, New Zealand from 1990 -- 2005. He later was a scientific reseacher in the field of genetic eye diseases. He has spoken worldwide on genetics, evolution and the anthropic argument for design. Denton #39;s current interests include defending the "anti Darwinian evolutionary position" and the design hypothesis formulated in his book Nature #39;s Destiny. Denton describes himself as an agnostic.From:AmoralDeistViews:0 0ratingsTime:00:42More inScience Technology

See more here:
Why should students be exposed to problems in evolutionary theory? - Dr. Michael J. Denton - Video

Fun with biochemistry Anthocyanin – Video

Posted on by


Fun with biochemistry Anthocyanin
A science tutor shows how you can test different chemical properties using an ingredient you can make in your own kitchen. http://www.ScienceTutorOnline.com is the website where you can learn to make your own anthocyanin, and do other biochemistry experiments. Science Tutor Online also gives you answers to your biology questions. I post a new biology tutoring video or science video every Monday evening. For more help learning science, go to httpFrom:ScienceTutorOnlineViews:0 0ratingsTime:02:42More inEducation

Link:
Fun with biochemistry Anthocyanin - Video

Hemoglobin Noir – Video

Posted on by


Hemoglobin Noir
A project for the Biochemistry class at UAF, Fall 2012 Additional Credits: Jonathan Quinones English Dubb Madame Hemoglobin has lost her love, Oxy Gen, and she goes to Inspector Genome to solve the case. Genome learns about sickle cell anemia, high altitude adaptations to hemoglobin, but the answer still comes as a shock. For Further Reading: Beall, CM Two routes to functional adaptation: Tibetan and Andean high altitude natives. Proceedings of the National Academy of Sciences. (2007) 104 (1) 8655-8660 Carey, HV, Martin, SL, Horwitz, BA, Yan, L., Bailey, SM, Podrabsky, J., Storz, JF, Ortiz, RM, Wong, RP, Lathrop, DA Elucidating Nature #39;s Solution to Heart, Lung, and Blood Diseases and Sleep Disorders. Circulation Research (2012) 110 (7) 915-21 Grispo, MT, Natarajan, C., Projecto-Garciaa, J., Moriyama, H., Weber, RE, Storz, JF Gene duplication and the evolution of hemoglobin isoform differentiation in birds. Journal of Biological Chemistry. (2012) 287 37647 37658 Storz, JF, Moriyama, H. Mechanisms of hemoglobin adaptation to high altitude hypoxia. High Altitude Medicine Biology. (2008) 9 (2) 148-157 Storz, JF, Scott, GR, Cheviron, ZA Phenotypic plasticity and genetic adaptation to high-altitude hypoxia in vertebrates. Journal of Experimental Biology. (2010) 213 4125-4136 Weber, RE, Jessen, TH, Malte, H., Tame, J. Mutant hemoglobins ( alpha;119-Ala and beta;55-Ser): functions related to high-altitude respiration in geese. American Physiological Society. (1993) 75 (6) 2646-2655From:Iris FletcherViews:1 0ratingsTime:14:01More inEducation

See the original post:
Hemoglobin Noir - Video

Officials estimate $45 million loss for UI if fiscal cliff deal isn’t reached

Posted on by

URBANA Scientists in the seven laboratories at the Institute for Genomic Biology are studying the essence of life.

From gene function to the classification of life forms to climate change, more than 140 professors from across campus collaborate on federally funded research worth more than $20 million.

Consider what would happen if a tenth of that money, $2 million, suddenly disappeared. It would mean, professors say, less money to support the graduate students and research scientists who do much of the lab work. A year or more lopped off multi-year projects. Perhaps some research questions left unanswered. Real jobs lost.

Now multiply that by a factor of 20, and it's clear why UI officials are keeping a wary eye on federal budget negotiations in Washington.

The impending "fiscal cliff" on Jan. 2 would force substantial cuts to government programs that support more than $140 billion of research nationwide each year. Unless Congress reaches a budget agreement, automatic spending cuts known as "sequestration" will slash research budgets by 8.2 percent across the board, according to an analysis from the federal Office of Management and Budget.

And UI Chancellor Phyllis Wise said a National Science Foundation official indicated recently that the agency is preparing for cuts of up to 10 percent.

Even 8.2 percent would be a significant hit for the UI's Urbana campus, whose federal grants and contracts totaled more than $400 million in fiscal 2012. And Urbana is the largest recipient of NSF awards, with $195 million. The Chicago campus, with its heavy emphasis on health sciences, spent more than $300 million in federal funding in fiscal 2012.

Some of the federal money goes toward Pell financial aid grants (which are protected from the "cliff") and other activities, but the bulk is for research.

Universitywide, an 8.2 percent cut would mean a loss of at least $45 million in research dollars, according to Lawrence Schook, UI vice president for research. He said 75 percent of that goes toward salaries for hundreds of research scientists and academic professionals earning, on average, $50,000 to $75,000 a year.

"If you look at Urbana, this is 200 to 300 real jobs," he said. "These are high-quality, highly educated people."

Here is the original post:
Officials estimate $45 million loss for UI if fiscal cliff deal isn't reached

Thomas Jefferson University Honoring Cancer Pioneer Axel Ullrich with Lennox K. Black International Prize

Posted on by

Newswise PHILADELPHIAThomas Jefferson University will honor the renowned biotech researcher whose discoveries led to a slew of innovative drugs that revolutionized treatment including Herceptinone of the first gene-based medications for breast cancerwith its prestigious Lennox K. Black International Prize for Excellence in Biomedical Research.

Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, will receive the recognition for his work in individualized medicine during a two-day symposium that will feature speakers from Jefferson, the National Institutes of Health (NIH), Johns Hopkins University, Genentech and former Kimmel Cancer Center at Jefferson Director Carlo Croce, M.D., Director of the Human Cancer Genetics Program at The Ohio State University.

The symposium, Individualized Medicine, will be held November 29 and 30 on the Jefferson campus at the Dorrance H. Hamilton Building, Connelly Auditorium, 1001 Locust Street. The prize award and keynote speech by Dr. Ullrich will begin at 2:30 p.m. on Nov. 29. Michael J. Vergare, M.D., Senior Vice President of Academic Affairs, and Professor and Chair of the Department of Psychiatry at Jefferson, will present the award to Dr. Ullrich on behalf of the University.

The prize is awarded every two years to recognize the impact of pioneering biomedical research on the alleviation of human disease and suffering. Another goal is to draw the international scientific research community together in recognition of the ability of the spirit of human inquiry to transcend national boundaries and divisions.

For the past 25 plus years, Dr. Ullrich has been a leader in the biotechnology world, translating many of his basic science discoveries into clinical applications. Dr. Ullrich and his teams research led to the development of the drug Humulin (human insulin for diabetes), which is the first therapeutic agent ever to be developed through gene-based technology.

Another product based on Dr. Ullrichs work is the anti-cancer drug Herceptin (trastuzumab). In the mid-1980s, Dr. Ullrich and collaborators discovered that 30 percent of breast cancer patients overexpress the HER2 gene, which is a gene involved in the development of invasive cancers. This was the basis for the development of a monoclonal antibody that inhibits HER2 production, known as Herceptin, which been used since the late 1990s to treat patients with metastatic breast cancer. It has been shown to improve overall survival and prevents tumor recurrence in many women.

Dr. Ullrich received his primary degree in biochemistry at the University of Tubingen, Germany, and his Ph.D. from the University of Heidelberg in Molecular Genetics in 1975. He worked as a senior scientist at Genentech in San Francisco from 1978 to 1988. Since then, he has been Managing Director of the Max Plank Institute of Biochemistry.

He also received the 2010 Wolf Prize for research on human proto-oncogenes and development of novel cancer therapies.

After the award and keynote speech are delivered, Marc S. Williams, M.D., Director of the Genomic Medicine Institute, Geisinger Health System, and David Nash, M.D., MBA, Dean of Jefferson School of Population Health, will address the symposium. A poster session and reception hosted by the Chairman of the symposium planning committee, Stephen C. Peiper, M.D., Peter A. Herbut Professor and Chair, in the Department of Pathology, Anatomy and Cell Biology at Jefferson, will follow.

Several researchers will speak on Nov. 30, beginning at 8:30 a.m., at the Bluemle Life Sciences Building, 233 S 10th Street, Room 101, on The Role of Structural Biology in Precision Medicine. That includes John M. Pascal, Ph.D., of the Department of Biochemistry and Molecular Biology at Jefferson, Wei Yang, Ph.D., a Senior Investigator and Section Chief at the National Institute of Diabetes and Digestive and Kidney Diseases at the NIH, Daniel J. Leahy, Ph.D., Professor of Biophysics and Biophysical Chemistry, Johns Hopkins University, and Chris Bowden, M.D., Vice President of Product Development for Signal Transduction Inhibitors, Genentech.

See the article here:
Thomas Jefferson University Honoring Cancer Pioneer Axel Ullrich with Lennox K. Black International Prize

Hypnotherapy – Video

Posted on by


Hypnotherapy
Mary Ida Kendall talks about her work as a hypnotherapist in the field of behavioral science. Hypnosis uses trance states to access and change feelings and thoughts to bring subconscious programming and conscious desires into synch with each other. Once in synch, creating the life we want becomes automatic and graceful. Ida #39;s varied clientele ranges from people in any type of recovery (health, trauma, grief, substance, eating, limiting habits) to individuals wanting a more complete expression creatively, emotionally or professionally.From:Mary Ida KendallViews:9 0ratingsTime:01:38More inEducation

Visit link:
Hypnotherapy - Video

TechTalk4HamOnt: Larissa D interviews Carol Leaman CEO

Posted on by


TechTalk4HamOnt: Larissa D interviews Carol Leaman CEO President of Axonify Inc.
Carol Leaman CEO President of Axonify Inc. Axonify (@Axonify) combines principles of behavioral science with the best qualities of gamified and social software to result in a new approach to e-learning and employee awareness mdash;one that empowers organizations to train faster, retain information effectively and perform better. Carol Leaman (@CarolLeaman) brings more than 20 years of leadership and technology executive experience to the company as she has a history of building start-ups into multi-million dollar successes. Most recently, Carol sold PostRank to Google after growing the company from a cool, free web tool, to a unique, customer-centric social media play in 2011. Prior to PostRank, she helmed RSS Solutions (enterprise class manufacturing software), and Fakespace (a high-end virtual reality company). She took Fakespace from $3 million to $30 million in revenue before orchestrating its acquisition in 2003, and sold RSS Solutions in 2006. Website: http://www.axonify.com Twitter: twitter.com twitter.com Facebook: http://www.facebook.com Our Links! Follow us on Twitter: twitter.com Like us on Facebook: http://www.facebook.com Add us to your Google+ Circle! plus.google.com Subscribe to the official Youtube Channel http://www.youtube.comFrom:TechTalk4HamOntViews:15 0ratingsTime:05:54More inScience Technology

Read more:
TechTalk4HamOnt: Larissa D interviews Carol Leaman CEO

Dr. Ana Diez Roux : The Science of Environmental Factors of Health – Video

Posted on by


Dr. Ana Diez Roux : The Science of Environmental Factors of Health
In this edition of The Science of Being Human: Profiles in Behavioral Science series, Dr. Ana Diez Roux discusses the Science of Environmental Factors of Health.From:NIHODViews:2 0ratingsTime:06:51More inEducation

Read the rest here:
Dr. Ana Diez Roux : The Science of Environmental Factors of Health - Video

A Reflection of Perfection: Plastic Surgery & Dermatology of NYC Launches New Website!

Posted on by

New York, Nov. 26, 2012 (GLOBE NEWSWIRE) -- The co-directors of Plastic Surgery & Dermatology of NYC, Elie Levine, MD and Jody Levine, MD, launched their newly designed website to better reflect the expertise of their practice and the exceptional results their patients have come to expect. The new website offers a comprehensive and informative platform for patients seeking to learn more about medical, surgical, and cosmetic solutions for women, men, and children. Plastic Surgery & Dermatology of NYC uses a unique, integrated approach by intertwining the parallel fields of dermatology and plastic surgery to treat both medical and aesthetic concerns ranging from minimal intervention skin care to the most advanced plastic surgery techniques.

Exceptional results produced by Dr. Elie Levine's facial, breast, non-invasive, and body contouring procedures, as well as Dr. Jody Levine's cosmetic laser, comprehensive skin care, and pediatric dermatology treatments, have distinguished Plastic Surgery & Dermatology of NYC among the top cosmetic and medical practices in New York City. Dr. Elie Levine offers a full range of the most sophisticated plastic surgery techniques, including procedures such as facelift, body lift, liposuction, breast augmentation, and scar revision. Dr. Jody Levine is an expert in a broad array of dermatologic treatments focused on prevention, maintenance, and enhancement, including leading-edge laser treatments, cosmetic injectables, microdermabrasion, and sclerotherapy. By combining the expertise of both doctors, Plastic Surgery & Dermatology of NYC creates a truly customized beauty regimen for each patient, which allows for extraordinary results with maximum enhancement.

Dr. Elie Levine said, "We're excited to launch our new website, which will help patients to gain a better understanding of treatments that might best suit their needs, whether they're seeking surgical enhancement, medical treatment, or anti-aging measures."

Dr. Jody Levine added, "Our new website was designed with our patients in mind, offering detailed and informative descriptions of available procedures, as well as a comprehensive before-and-after gallery that shows actual patient results."

Dr. Elie Levine is the Director of Plastic Surgery at Plastic Surgery & Dermatology of NYC. He graduated in the top 10% of his class from Yale School of Medicine and continued his extensive training at The Mount Sinai Medical Center. With a skilled hand and artistic eye, Dr. Elie Levine achieves outstanding results that are transformational, yet discreet. He believes that patients should appear beautiful, youthful, and natural-looking, but never as though they have had plastic surgery. With expertise in all areas of plastic and reconstructive surgery, Dr. Elie Levine specializes in combining procedures and treatments to optimize results and allow patients to achieve the rejuvenation and confidence boost they seek.

Dr. Jody Levine, the Director of Dermatology at Plastic Surgery & Dermatology of NYC, also graduated with honors from Yale School of Medicine, with continued training at The Mount Sinai Medical Center. With dual board-certification in pediatrics, as well as cosmetic and surgical dermatology, Dr. Jody Levine is uniquely qualified to provide comprehensive cosmetic, medical, and laser dermatological treatments for the entire family. Skin care needs change during the course of a lifetime, and Dr. Jody Levine guides patients through the seasons and years, customizing treatments according to changes in hormones, age, lifestyle, and other circumstances that make particular treatments more effective than others. Her ability to treat people from infancy through adulthood gives her patients an added level of comfort and convenience. Parents no longer need to split their time between doctor visits; Dr. Levine can easily treat both parents and their children in consecutive appointments.

Elie Levine, MD, Jody Levine, MD, and their staff look forward to discussing any questions patients may have about plastic surgery in NYC, dermatology in New York, or any of the comprehensive cosmetic, medical, and surgical services they offer at Plastic Surgery & Dermatology of NYC. Patients may contact their New York City office at 212.988.1800, or request an appointment online for a personal consultation.

Read this article:
A Reflection of Perfection: Plastic Surgery & Dermatology of NYC Launches New Website!